Subclinical myocardial dysfunction in patients with reverse-remodeled dilated cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 25, Issue 7, 2012, Pages 726-732

  Okada, Mariko ^a   Tanaka, Hidekazu ^a   Matsumoto, Kensuke ^a   Ryo, Keiko ^a   Kawai, Hiroya ^a   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Reverse remodeled dilated cardiomyopathy; Speckle tracking strain rate; Subclinical myocardial dysfunction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLE; EXERCISE TEST; FEMALE; HEART AFTERLOAD; HEART EJECTION FRACTION; HUMAN; ISOMETRIC HANDGRIP STRESS TEST; MALE; MYOCARDIAL DISEASE; RETROSPECTIVE STUDY; SYSTOLE;

CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; ELASTICITY IMAGING TECHNIQUES; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84862978623     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2012.04.001     Document Type: Article

References (35)

1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47:525-31. (Pubitemid 11137647)
2. Ikram H, Williamson HG, Won M, Crozier IG, Wells EJ. The course of idiopathic dilated cardiomyopathy in new zealand. Br Heart J 1987;57: 521-7. (Pubitemid 17082525)
3. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
4. Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: Clinical correlates and prognostic significance. Am Heart J 2003;145:292-9. (Pubitemid 36207951)
5. Rogers WJ, Johnstone DE, Yusuf S, Weiner DH, Gallagher P, Bittner VA, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. The solvd investigators. J Am Coll Cardiol 1994;23:393-400. (Pubitemid 24049371)
6. Francis GS, Johnson TH, Ziesche S, Berg M, Boosalis P, Cohn JN. Marked spontaneous improvement in ejection fraction in patients with congestive heart failure. Am J Med 1990;89:303-7. (Pubitemid 20323256)
7. Cross AM Jr., Steenbergen C, Higginbotham MB. Recovery of left ventricular function in acute nonischemic congestive cardiomyopathy. Am Heart J 1995;129:24-30.
8. Figulla HR, Rahlf G, Nieger M, Luig H, Kreuzer H. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 1985;71: 1095-104. (Pubitemid 15036355)
9. Kubo H, Margulies KB, Piacentino V III, Gaughan JP, Houser SR. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 2001;104:1012-8. (Pubitemid 32803877)
10. Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S, et al. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with metoprolol therapy. J Nucl Med 2003;44:1604-11. (Pubitemid 39663332)
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr 2005;18: 1440-63. (Pubitemid 41821197)
12. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8. (Pubitemid 16119719)
13. Takamura T, Dohi K, Onishi K, Tanabe M, Sugiura E, Nakajima H, et al. Left ventricular contraction-relaxation coupling in normal, hypertrophic, and failing myocardium quantified by speckle-tracking global strain and strain rate imaging. J Am Soc Echocardiogr 2010;23:747-54.
14. Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ. Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009;54:618-24.
15. Kosmala W, Plaksej R, Strotmann JM,Weigel C, Herrmann S, Niemann M, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr 2008;21:1309-17.
16. Svealv BG, Olofsson EL, Andersson B. Ventricular long-axis function is of major importance for long-term survival in patients with heart failure. Heart 2008;94:284-9. (Pubitemid 351303416)
17. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr 2008;21:1138-44.
18. Kitaoka H, Takata J, Yabe T, Hitomi N, Furuno T, Doi YL. Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart 1999;81: 523-7. (Pubitemid 29234314)
19. Pratali L, Picano E, Otasevic P, Vigna C, Palinkas A, Cortigiani L, et al. Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol 2001;88:1374-8. (Pubitemid 34008680)
20. Klewer SE, Goldberg SJ, Donnerstein RL, Berg RA, Hutter JJ Jr. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol 1992;19:394-401.
21. Brown BG, Lee AB, Bolson EL, Dodge HT. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 1984;70:18-24. (Pubitemid 14084061)
22. Neglia D, Sambuceti G, Giorgetti A, Bartoli M, Salvadori P, Sorace O, et al. Effects of long-term treatment with verapamil on left ventricular function and myocardial blood flow in patients with dilated cardiomyopathy without overt heart failure. J Cardiovasc Pharmacol 2000;36:744-50.
23. Scognamiglio R, Avogaro A, Casara D, Crepaldi C, Marin M, Palisi M, et al. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31: 404-12. (Pubitemid 28153462)
24. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, FowlerMB. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79:483-90. (Pubitemid 19087699)
25. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9. (Pubitemid 44088349)
26. Meluzin J, Spinarova L, Hude P, Krejci J, Poloczkova H, Podrouzkova H, et al. Left ventricular mechanics in idiopathic dilated cardiomyopathy: Systolic-diastolic coupling and torsion. J Am Soc Echocardiogr 2009;22: 486-93.
27. Malaty AN, Shah DJ, Abdelkarim AR, Nagueh SF. Relation of replacement fibrosis to left ventricular diastolic function in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 2011;24:333-8.
28. Scognamiglio R, Negut C, de Kreuizenberg SV, Palisi M, Tiengo A, Avogaro A. Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patients. Clin Cardiol 2005;28:93-9. (Pubitemid 40209383)
29. Scognamiglio R, Negut C, Piccolotto R, Dioguardi FS, Tiengo A, Avogaro A. Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus. Am Heart J 2004; 147:1106-12. (Pubitemid 38880972)
30. Peter CA, Jones RH. Effects of isometric handgrip and dynamic exercise on left-ventricular function. J Nucl Med 1980;21:1131-8. (Pubitemid 11196757)
31. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003;41:611-7. (Pubitemid 36223327)
32. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004;110:558-65. (Pubitemid 39031173)
33. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-33.
34. Tanaka H, Hara H, Adelstein EC, Schwartzman D, Saba S, Gorcsan J III. Comparative mechanical activation mapping of RV pacing to LBBB by and 3D speckle tracking and association with response to resynchronization therapy. JACC Cardiovasc Imaging 2010;3:461-71.
35. Tanaka H, Hara H, Saba S, Gorcsan J III. Usefulness of three-dimensional speckle tracking strain to quantify dyssynchrony and the site of latest mechanical activation. Am J Cardiol 2010;105:235-42.